Judith M Bliss - JoVE Visualize

Showing results (41-50 of 98) with videos related to

Pageof 10

Sort By:

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021

Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast CancersMilana A Bergamino, Gabriele Morani, Joel Parker, et al.

Breast Cancer Research : BCR|September 12, 2022

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC studyElena Lopez-Knowles, Simone Detre, Margaret Hills, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2026

Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-studySaranya Ravindra, Fay H Cafferty, Emma Harris, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012

Dissecting the heterogeneity of triple-negative breast cancerOtto Metzger-Filho, Andrew Tutt, Evandro de Azambuja, et al.

Nature Communications|July 7, 2023

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.

Trials|December 31, 2015

Exploring the role and function of trial steering committees: results of an expert panel meetingNicola L Harman, Elizabeth J Conroy, Steff C Lewis, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid TumorsMartine J Piccart, Florentine S Hilbers, Judith M Bliss, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020

ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT TrialsNicholas C Turner, Claire Swift, Lucy Kilburn, et al.

The Lancet. Oncology|July 5, 2011

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyTom Treasure, Loic Lang-Lazdunski, David Waller, et al.

The Lancet. Oncology|November 5, 2020

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trialIan Smith, John Robertson, Lucy Kilburn, et al.

Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:

Pageof 10

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021

Impact of Duration of Neoadjuvant Aromatase Inhibitors on Molecular Expression Profiles in Estrogen Receptor-positive Breast CancersMilana A Bergamino, Gabriele Morani, Joel Parker, et al.

Breast Cancer Research : BCR|September 12, 2022

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC studyElena Lopez-Knowles, Simone Detre, Margaret Hills, et al.

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 2026

Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-studySaranya Ravindra, Fay H Cafferty, Emma Harris, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012

Dissecting the heterogeneity of triple-negative breast cancerOtto Metzger-Filho, Andrew Tutt, Evandro de Azambuja, et al.

Nature Communications|July 7, 2023

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancersEugene F Schuster, Elena Lopez-Knowles, Anastasia Alataki, et al.

Trials|December 31, 2015

Exploring the role and function of trial steering committees: results of an expert panel meetingNicola L Harman, Elizabeth J Conroy, Steff C Lewis, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid TumorsMartine J Piccart, Florentine S Hilbers, Judith M Bliss, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020

ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT TrialsNicholas C Turner, Claire Swift, Lucy Kilburn, et al.

The Lancet. Oncology|July 5, 2011

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyTom Treasure, Loic Lang-Lazdunski, David Waller, et al.

The Lancet. Oncology|November 5, 2020

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trialIan Smith, John Robertson, Lucy Kilburn, et al.

Pageof 10